Contract HHSF223201610004I

Biopharma Services USA · Department Of Health And Human Services · February 11, 2016

Firm Fixed PriceFull & Open CompetitionNAICS 541690

Biopharma Services USA was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on February 11, 2016 for $3,000 of work in other scientific and technical consulting services. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 4, 2020. If all options are exercised, the contract could reach $20.00 million.

Obligated to date
$2.5K
$2,500
Potential value
$20.00M
if all options exercised
Modifications
5
Latest August 4, 2020

Contract details

PIID
HHSF223201610004I
Award type
Pricing
Firm Fixed Price
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541690 · Other Scientific And Technical Consulting Services
Product / service
Special Studies/Analysis- Regulatory
First action
February 11, 2016
Latest action
August 4, 2020

Description

EXERCISE OPTION YEAR 4 IDIQ CONTRACT HHSF223201610004I - N VIVO STUDY OF GENERIC DRUG PRODUCTS IN HUMAN SUBJECTS

Modification timeline

  • August 4, 2020
    Mod P00004
    $0
  • August 4, 2020
    Mod P00005
    MODIFICATION 5 IS TO CORRECT THE MODIFICATION 4 TO CORRECT THE OPTION YEARS FROM 3 TO 4.
    $0
  • August 1, 2019
    Mod P00003
    EXERCISE OPTION YEAR 3
    $0
  • September 25, 2018
    Mod 2
    IGF::OT::IGF - EXERCISE OPTION YEAR 2 - IDIQ CONTRACT ENTITLED "VIVO STUDY OF GENERIC DRUG PRODUCTS IN HUMAN SUBJECTS".
    $0
  • March 28, 2017
    Mod 1
    IGF::OT::IGF - EXERCISE OPTION YEAR 1 - IDIQ CONTRACT ENTITLED "VIVO STUDY OF GENERIC DRUG PRODUCTS IN HUMAN SUBJECTS".
    $0
  • February 11, 2016
    Base award
    IGF::OT::IGF - IDIQ CONTRACT ENTITLED "VIVO STUDY OF GENERIC DRUG PRODUCTS IN HUMAN SUBJECTS".
    $2.5K

Similar contracts

RecipientAgencyDateObligated
Kelly Services, Inc.Department Of Health And Human ServicesApril 1, 2026$3.49M
Kelly Services, Inc.Department Of Health And Human ServicesApril 1, 2026$3.83M
Kelly Services, Inc.Department Of Health And Human ServicesApril 1, 2026$2.35M
Gap Solutions, Inc.Department Of Health And Human ServicesApril 1, 2026$1.02M
Midnight Sun Technologies LlcDepartment Of Health And Human ServicesApril 1, 2026$308.3K
Lala, Raymond FDepartment Of Health And Human ServicesApril 1, 2026$18.6K

Top contractors in NAICS 541690

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HHSF223201610004I?

Contract HHSF223201610004I is a federal contract awarded to Biopharma Services USA by Department Of Health And Human Services on February 11, 2016 for $3,000 of work classified under OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES. It has been modified 5 times since the base award.

Who won contract HHSF223201610004I?

Biopharma Services USA won contract HHSF223201610004I from Department Of Health And Human Services.

How much is contract HHSF223201610004I worth?

Contract HHSF223201610004I has obligated $3,000 to date, with a total potential value of $20.00 million if all options are exercised.